Redeye takes a positive stance towards Speqta’s direct share issue despite somewhat lowering its Base Case. While coming at a substantial discount of 31%, bringing in SEK55m and a 33.5% dilution, the direct share issue significantly reduces the risk in Speqta – as we believe the funds are enough to turn Speqta profitable.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Speqta - Direct Share Issue Likely Sufficient to Reach Profitability

© Modular Finance, source Nordic Press Releases